Capital International Investors Royalty Pharma PLC Transaction History
Capital International Investors
- $557 Billion
- Q2 2025
A detailed history of Capital International Investors transactions in Royalty Pharma PLC stock. As of the latest transaction made, Capital International Investors holds 21,880,620 shares of RPRX stock, worth $785 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
21,880,620Holding current value
$785 Million% of portfolio
0.14%Shares
13 transactions
Others Institutions Holding RPRX
# of Institutions
508Shares Held
319MCall Options Held
2.51MPut Options Held
940K-
Morgan Stanley New York, NY41MShares$1.47 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.3 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$825 Million0.01% of portfolio
-
Baillie Gifford & CO18MShares$646 Million0.51% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$436 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...